Anales de la RANM

64 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 FENOTIPO DE LA Β-TALASEMIA INTERMEDIA Paloma Ropero, et al. An RANM. 2021;138(01): 60 - 71 Tabla 3.- β-talasemia asociada con triplicaciones del gen α Paciente Edad/ Sexo Hb (g/dL) VCM (fL) HCM (pg) ADE (%) Ret (%) I 14/H 8.3*§ 57.5 18.7 17.7 4.4 II 45/H 6.3*§ 88.8 25.9 29.2 2.3 III 33/M 9.8 73.1 23.2 16.3 3.8 IV 6m/M 9.7 60.8 18.8 22.9 3.1 V 7/M 8.1 60.3 19.8 24.6 3.2 VI 2/M 8.3 56.2 18.0 19.0 3.0 VII 30/M 8.3 74.0 22.6 21.2 5.1 VIII 42/M 8.4 65.6 20.3 17.5 2.3 IX 5/M 8.5 72.9 22.3 25.8 4.7 X 16/H 8.6 57.8 18.3 21.6 3.0 XI X/H 8.8 60.8 18.8 25.6 2.7 XII 65/M 8.8 65.9 20.4 23.7 3.0 XIII 33/M 8.9 62.5 19.8 21.3 2.0 XIV 32/H 9.1 61.2 19.6 17.1 2.1 XV 7/M 9.3 57.8 18.4 18.1 2.4 XVI 32/H 9.3 72.0 21.5 21.1 3.0 XVII 58/H 9.3 81.3 25.3 26.8 10.4 XVIII 23/M 9.7 57.9 18.8 21.5 2.0 XIX** 29/M 9.8 65.1 19.7 19.2 1.9 XX 29/M 9.8 60.6 20.5 11.7 1.2 XXI 6/H 9.9 55.8 18.0 21.3 0.8 XXII 32/M 10.1 59.3 18.7 16.7 12.0 XXIII 59/H 10.4§ 65.4 20.8 17.3 1.3 XXIV X/H 10.5 63.7 18.2 18.6 1.9 XXV 8/H 10.5 65.0 20.0 19.0 0.6 XXVI 42/H 10.5 70.4 20.8 23.1 3.7 XXVII 3/H 10.6 58.0 19.0 19.8 0.5 XXVIII 50/H 10.7 60.2 19.2 17.4 0.8 XXIX*** X/H 11.1 78.3 23.0 24.9 7.3 XXX 20/M 7.2** 72.4 20.1 22.5 3.7 XXXI 20/M 8.3 73.1 22.6 21.2 5.1 XXXII 34/M 9.0 64.2 21.2 20.9 2.6 XXXIII 60/M 9.1 74.5 26.0 26.0 5.5 XXXIV 25/M 9.2 64.4 19.1 16.5 2.1 XXXV 6m/M 9.4 61.0 20.0 18.0 1.2 XXXVI 23/M 9.6 63.9 21.1 16.5 1.6 XXXVII 20/M 9.9 62.1 20.8 14.3 1.1 Grupo I II